(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)((2S)-2-METHYL-2-(7-METHYL-1H-BENZIMIDAZOL-2-YL)-1-PYRROLIDINYL)METHANONE
UNII LD4CC296DK
Substance Identification & Data
This profile provides standardized clinical and technical data for (5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)((2s)-2-methyl-2-(7-methyl-1h-benzimidazol-2-yl)-1-pyrrolidinyl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LD4CC296DK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1505484-96-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H24N6O2 RKLZNOXRSXQGAQ-QHCPKHFHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)((2s)-2-methyl-2-(7-methyl-1h-benzimidazol-2-yl)-1-pyrrolidinyl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.